Neoadjuvant therapy
Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)
PUBLICATION: Annals of Surgical Oncology; October 2014, Volume 21, Issue Read More